BSEEvoq Remedies LtdCriticalNegative
Announced Wed, 10 Jun · 18:11 IST

Corporate Insolvency Resolution process (CIRP) - Admission of application by Tribunal

Nclt Insolvency AdmittedRegulatory & Legal View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.2%1-day move
₹2.90
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-6.2-11.7-13.4-11.7-13.1-9.0-18.6-20.3
Up moveDown movePending
AI summary

Evoq Remedies Limited has informed the BSE that the National Company Law Tribunal (NCLT), Ahmedabad has admitted an insolvency application against the company. The application was filed by M/s. Harbhole Agrotech (an operational creditor) through its proprietor on 20th April 2026 under Section 9 of the Insolvency and Bankruptcy Code (IBC), 2016. This means the company's Corporate Insolvency Resolution Process (CIRP) has formally commenced. An Interim Resolution Professional is likely to be appointed to manage the company's affairs going forward.

Likely market impact

This is a significant negative development for shareholders — the stock will typically face sharp selling pressure as CIRP admission often leads to trading restrictions, management change, and possible restructuring or liquidation. Shareholders may face substantial erosion of value depending on the resolution outcome.